Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Strober

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Journal of the American Academy of Dermatology|April 25, 2009
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus ConferenceRobert E Kalb, Bruce Strober, Gerald Weinstein, et al.
Clinics in Dermatology|December 15, 2016
Psoriasis in adults and children: Kids are not just little peopleElle H de Moll, Mary Wu Chang, Bruce Strober
Journal of the American Academy of Dermatology|May 17, 2011
Methotrexate and psoriasis: consensus conferenceRobert E Kalb, Bruce Strober, Gerald Weinstein, et al.
Journal of Psoriasis and Psoriatic Arthritis|January 8, 2024
Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasisPaige Kingston, Andrew Blauvelt, Bruce Strober, et al.
Journal of Drugs in Dermatology : JDD|June 8, 2022
Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus PanelBruce Strober, John Fox, Eliot Jekowsky, et al.
Journal of Dermatological Science|December 3, 2019
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL studyBruce Strober, Ali Alikhan, Benjamin Lockshin, et al.
Journal of the American Academy of Dermatology|May 21, 2020
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasisLinda Stein Gold, Jes B Hansen, Dharm Patel, et al.
Journal of the American Academy of Dermatology|June 24, 2008
Rethinking eligibility creepMaryanne Kazanis, Craig Leonardi, Ken Gordon, et al.
Journal of the American Academy of Dermatology|July 27, 2025
Healthcare resource utilization and economic burden in generalized pustular psoriasis (GPP) among U.S. adults: A large claims database analysisMark Lebwohl, Bhargav Lakshminarasimhan, Layla Lavasani, et al.
Journal of the American Academy of Dermatology|August 28, 2024
Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysisBruce Strober, Ahmed M Soliman, Chao Li, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Journal of the American Academy of Dermatology|April 25, 2009
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus ConferenceRobert E Kalb, Bruce Strober, Gerald Weinstein, et al.
Clinics in Dermatology|December 15, 2016
Psoriasis in adults and children: Kids are not just little peopleElle H de Moll, Mary Wu Chang, Bruce Strober
Journal of the American Academy of Dermatology|May 17, 2011
Methotrexate and psoriasis: consensus conferenceRobert E Kalb, Bruce Strober, Gerald Weinstein, et al.
Journal of Psoriasis and Psoriatic Arthritis|January 8, 2024
Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasisPaige Kingston, Andrew Blauvelt, Bruce Strober, et al.
Journal of Drugs in Dermatology : JDD|June 8, 2022
Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus PanelBruce Strober, John Fox, Eliot Jekowsky, et al.
Journal of Dermatological Science|December 3, 2019
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL studyBruce Strober, Ali Alikhan, Benjamin Lockshin, et al.
Journal of the American Academy of Dermatology|May 21, 2020
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasisLinda Stein Gold, Jes B Hansen, Dharm Patel, et al.
Journal of the American Academy of Dermatology|June 24, 2008
Rethinking eligibility creepMaryanne Kazanis, Craig Leonardi, Ken Gordon, et al.
Journal of the American Academy of Dermatology|July 27, 2025
Healthcare resource utilization and economic burden in generalized pustular psoriasis (GPP) among U.S. adults: A large claims database analysisMark Lebwohl, Bhargav Lakshminarasimhan, Layla Lavasani, et al.
Journal of the American Academy of Dermatology|August 28, 2024
Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysisBruce Strober, Ahmed M Soliman, Chao Li, et al.
Pageof 13